abstract |
The invention relates to novel immunoglobulin-producing hybrid cell lines which are produced by cell fusion of myeloma cells with mouse spleen cells immunized against human interferon of type a according to known methods, the antibodies formed during the growth of these cells and their use in the purification, diagnosis and detection of Human interferon. |